Omeros reported $712K in Stock for its fiscal quarter ending in September of 2021.





Stock Change Date
Adma Biologics USD 239.31M 17.22M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Cytokinetics USD 380K 226K Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
MacroGenics USD 9.5M 1.59M Mar/2026
Omeros USD 712K 266K Sep/2021
Pacira USD 134.57M 15.8M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Rockwell Medical USD 4.16M 885K Jun/2025
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026